​

Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?

OverviewForecastRevenueFinancialsChart

Bicycle Therapeutics Ownership Summary

Bicycle Therapeutics is owned by 3.22% institutional investors, 4.42% insiders, and 92.36% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.71% of BCYC shares. Westfield Capital Mgt Co Sm-Cap Gr Eq is the top mutual fund, with 1.47% of its assets in Bicycle Therapeutics shares.

BCYC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicycle Therapeutics3.22%4.42%92.36%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp10.89M15.71%$50.51M
Fcpm iii services b.v.3.47M5.01%$16.09M
Armistice capital3.40M4.90%$15.77M
Long focus capital management3.31M4.78%$15.36M
Acadian asset management1.97M2.84%$9.11M
Gsk1.53M2.21%$7.10M
Price t rowe associates inc /md/1.03M1.48%$4.77M
Renaissance979.30K1.41%$4.54M
Blackrock402.22K0.95%$8.14M
Bank of america corp /de/383.80K0.90%$7.77M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aquilo capital management171.69K2.61%$1.46M
Fcpm iii services b.v.3.47M2.23%$16.09M
Birchview capital, lp463.60K1.22%$2.15M
Gsk1.53M1.18%$7.10M
Rangeley capital232.26K1.05%$1.08M
Peapod lane capital121.11K0.45%$550.21K
Long focus capital management3.31M0.40%$15.36M
Diadema partners lp476.42K0.38%$2.21M
Baker bros. advisors lp10.89M0.29%$50.51M
Armistice capital3.40M0.28%$15.77M

Top Buyers

HolderShares% AssetsChange
Long focus capital management3.31M0.40%1.68M
Diadema partners lp476.42K0.38%476.42K
Renaissance979.30K0.01%412.70K
Marshall wace, llp377.33K0.00%338.54K
Qube research308.62K0.00%308.62K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---3.25M
Westfield capital management co lp---3.02M
Siren---1.56M
Deep track capital, lp---1.20M
Candriam s.c.a.---1.19M

New Positions

HolderShares% AssetsChangeValue
Diadema partners lp476.42K0.38%476.42K$2.21M
Qube research308.62K0.00%308.62K$1.43M
Peapod lane capital121.11K0.45%121.11K$550.21K
Persistent asset partners120.44K0.21%120.44K$558.83K
Entrypoint capital63.91K0.09%63.91K$296.52K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-4.00
Northwestern mutual wealth management-5.00
Rockefeller capital management-5.00
Mather group, llc.-5.00
Eversource wealth advisors-6.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202636-68.70%2,227,370-94.31%30.10%20-64.91%6-79.31%
Dec 31, 202568-33.98%13,199,592-64.23%190.67%32-34.69%19-17.39%
Sep 30, 202594-16.07%32,600,347-18.41%471.41%46-26.98%20-4.76%
Jun 30, 202511518.56%41,177,900-1.34%591.63%6653.49%21-30.00%
Mar 31, 20251-99.00%68,943-99.84%-0.00%--100.00%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Westfield Capital Mgt Co Sm-Cap Gr Eq1.02M1.47%30.53K
Harbor Small Cap Growth Instl1.02M1.47%30.53K
Candriam Eqs L Biotech C USD Cap825.13K1.18%-
T. Rowe Price Health Sciences628.42K0.90%-
International Biotechnology Ord615.83K0.88%-
BNP Paribas Health Cr Innovtr Cl Cap568.51K0.82%568.51K
Principal U.S. Small Cap Select Equity523.30K0.75%-44.50K
Principal U.S. Small Cap Equity523.30K0.75%-44.50K
Principal SmallCap R5511.20K0.73%-4.90K
Candriam Global Equities Oncology492.11K0.71%125.18K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 06, 2026Perry Jennifer Scott Chief Operating OfficerSell$1.45K
Jul 06, 2026Perry Jennifer Scott Chief Operating OfficerSell$185.33
Jul 02, 2026Perry Jennifer Scott Chief Operating OfficerSell$4.42K
Jul 02, 2026Skynner Michael CHIEF SCIENTIFIC OFFICERSell$7.94K
Jul 06, 2026Skynner Michael CHIEF SCIENTIFIC OFFICERSell$2.29K

Insider Transactions Trends

DateBuySell
2026 Q3-11
2026 Q2-11
2026 Q1-13
2025 Q4-13
2025 Q3-11

BCYC Ownership FAQ

Who Owns Bicycle Therapeutics?

Bicycle Therapeutics shareholders are primarily institutional investors at 3.21%, followed by 4.42% insiders and 92.36% retail investors. The average institutional ownership in Bicycle Therapeutics's industry, Biotech Stocks , is 49.09%, which Bicycle Therapeutics falls below.

Who owns the most shares of Bicycle Therapeutics?

Bicycle Therapeutics’s largest shareholders are Baker bros. advisors lp (10.89M shares, 15.71%), Fcpm iii services b.v. (3.47M shares, 5.01%), and Armistice capital (3.4M shares, 4.90%). Together, they hold 25.62% of Bicycle Therapeutics’s total shares outstanding.

Does Blackrock own Bicycle Therapeutics?

Yes, BlackRock owns 0.95% of Bicycle Therapeutics, totaling 402.22K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.14M$. In the last quarter, BlackRock decreased its holdings by -173K shares, a -30.05% change.

Who is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested?

Aquilo capital management is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.61% of its assets in 171.7K Bicycle Therapeutics shares, valued at 1.46M$.

Who is the top mutual fund holder of Bicycle Therapeutics shares?

Westfield Capital Mgt Co Sm-Cap Gr Eq is the top mutual fund holder of Bicycle Therapeutics shares, with 1.47% of its total shares outstanding invested in 1.02M Bicycle Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools